Search

Displaying results 641 - 650 of 2817 in total
  1. Drug

    Vimseltinib

    go.drugbank.com/drugs/DB17520
    ApprovedInvestigational

    [L52230,A265035] Vimseltinib - under the brand name Romvimza - was approved by the FDA in February 2025 for the treatment of tenosynovial giant cell tumours for which surgical resection is not appropriate

    Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
  2. Drug

    Altropane

    go.drugbank.com/drugs/DB04947
    Investigational

    Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and

  3. Drug

    Telotristat

    go.drugbank.com/drugs/DB14218
    Investigational

    [Telotristat ethyl] (brand name Xermelo) is a prodrug of telotristat.

  4. Indication

    Gastric Ulcer

    go.drugbank.com/conditions/DBCOND0031714
    Drugs: Aluminium glycinate · Aluminum hydroxide · Calcium carbonate · Dimethicone · Ibuprofen · Kaolin +13 more
    Synonyms: GU, Gastric Ulcer (GU)
  5. Drug

    Mechlorethamine

    go.drugbank.com/drugs/DB00888
    ApprovedInvestigational

    The FDA granted marketing approval for the orphan drug Valchlor (mechlorethamine) gel on August 23, 2013 for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (CTCL

  6. Drug

    Relugolix

    go.drugbank.com/drugs/DB11853
    ApprovedInvestigational

    It was first approved in Japan in 2019, under the brand name Relumina, for the symptomatic treatment of uterine fibroids,[A225816] and more recently by the United States' FDA in 2020, under the brand name

    Categories: P-glycoprotein inhibitors, P-glycoprotein substrates
  7. Drug

    Carnosine

    go.drugbank.com/drugs/DB11695
    Investigational

    Carnosine has been investigated for the treatment of Gulf War Illness.

  8. Drug

    Radotinib

    go.drugbank.com/drugs/DB12323
    Investigational

    Radotinib is under investigation for the treatment of Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

  9. Target

    Integrin beta-7

    go.drugbank.com/bio_entities/BE0003414
    TargetHumans

    Integrin ITGA4/ITGB7 (alpha-4/beta-7) (Peyer patches-specific homing receptor LPAM-1) is an adhesion molecule that mediates lymphocyte migration and homing to gut-associated lymphoid tissue (GALT) (Probable

    Synonyms: Gut homing receptor beta subunit
  10. Drug

    PI-166

    go.drugbank.com/drugs/DB05859
    Experimental

    PI-166 is a small organic compound with specific avidity to liver cancer cells.